Page last updated: 2024-10-29

itopride and Parkinson Disease, Secondary

itopride has been researched along with Parkinson Disease, Secondary in 1 studies

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byun, JH1
Cho, H1
Kim, YJ1
Kim, JS1
Baik, JS1
Jang, S1
Ma, HI1

Other Studies

1 other study available for itopride and Parkinson Disease, Secondary

ArticleYear
Trends in the Prevalence of Drug-Induced Parkinsonism in Korea.
    Yonsei medical journal, 2019, Volume: 60, Issue:8

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzamides; Benzyl Compounds; Drug Prescriptions; Femal

2019